1.Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
Seung Hyeun LEE ; Sue In CHOI ; Ji Sung LEE ; Chul Hwan KIM ; Won Jai JUNG ; Eun Joo LEE ; Kyung Hoon MIN ; Gyu Young HUR ; Seung Heon LEE ; Sung Yong LEE ; Je Hyeong KIM ; Sang Yeub LEE ; Chol SHIN ; Jae Jeong SHIM ; Kyung Ho KANG ; Kwang Ho IN
Cancer Research and Treatment 2017;49(1):141-149
PURPOSE: Reactive oxygen species modulator 1 (Romo1) is a key mediator of intracellular reactive oxygen species production. However, examination of the clinical usefulness of Romo1 in cancers has been limited. We evaluated the association of Romo1 expression with clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy. MATERIALS AND METHODS: Romo1 expression in tumor tissue was examined by immunohistochemistry and evaluated by histological score. Survival analyses were performed according to Romo1 expression and the association between Romo1 expression and clinical parameters was evaluated. RESULTS: A total of 88 tumor specimens were analyzed. Significantly shorter median progression-free survival (PFS) was observed in the high Romo1 group compared with the low Romo1 group (4.5 months vs. 9.8 months, p < 0.001), and the median overall survival (OS) of the high Romo1 group was also significantly shorter than that of the low Romo1 group (8.4 months vs. 15.5 months, p < 0.001). Results of multivariate analyses showed significant association of high Romo1 expression with both poor PFS (hazard ratio [HR], 2.75; 95% confidence interval [CI], 1.71 to 4.44) and poor OS (HR, 3.99; 95% CI, 2.36 to 6.74). Results of the subgroup analysis showed a similar association regardless of tumor histology. Romo1 expression showed no association with any clinical parameter including age, sex, smoking status, stage, differentiation, or tumor histology. CONCLUSION: Romo1 overexpression was associated with poor response to treatment and shorter survival in advanced NSCLC patients treated with platinum-based chemotherapy. Romo1 could be a potential adverse predictive marker in this setting.
Biomarkers
;
Carcinoma, Non-Small-Cell Lung*
;
Disease-Free Survival
;
Drug Therapy*
;
Humans
;
Immunohistochemistry
;
Lung Neoplasms
;
Multivariate Analysis
;
Platinum
;
Prognosis
;
Reactive Oxygen Species*
;
Smoke
;
Smoking
2.A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea.
Yong Joo KIM ; Peipei LI ; Jong Myeon HONG ; Keun Ho RYU ; Eunwoo NAM ; Mi Soo CHANG
Journal of Korean Medical Science 2017;32(5):810-816
The antibody to hepatitis B surface antigen (anti-HBs) seropositivity rate after 3 doses of hepatitis B virus (HBV) vaccination during infancy period is known to be higher than 90%. However, a considerable number of vaccines do not form protective anti-HBs or chronologic decrease of anti-HBs. We retrospectively collected data of HBV serologic test results in 20,738 individuals from 2000 to 2015. After exclusion criteria were applied, 19,072 individuals were included. We analyzed the anti-HBs seropositivity rate, anti-HBs disappearance rate, anti-HBs positive seroconversion rate after receiving a booster vaccine, and the difference in anti-HBs positivity between the 2 groups; group A (born before 2005, while both recombinant vaccines and plasma-derived vaccines were used) and group B (born after 2005, when only recombinant vaccines were used by national regulation). The anti-HBs seropositivity rate was 55.8%, but there was a significant difference in the rate of seropositivity for anti-HBs between the group A and B (53.0% vs. 78.1%, P < 0.001). There was no significant age-adjusted difference in the mean seropositivity rate between the 2 groups (P = 0.058). In addition, the anti-HBs positivity rate was significantly lower in the group A as compared with the group B during infancy (83.1% vs. 92.1%, P < 0.001). A total of 1,106 anti-HBs-positive subjects underwent serologic tests more than twice. Of these, 217 subjects (19.6%) showed anti-HBs disappearance. After booster vaccinations, 87.4% (83/95) achieved seroconversion from seronegative to seropositive. Our results highlight the importance of lifelong protection against HBV and the possible necessity of booster vaccination after adolescent period.
Adolescent
;
Child
;
Hepatitis B Surface Antigens
;
Hepatitis B virus
;
Hepatitis B*
;
Hepatitis*
;
Humans
;
Korea*
;
Retrospective Studies
;
Seroconversion
;
Serologic Tests
;
Vaccination*
;
Vaccines
;
Vaccines, Synthetic
3.Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
Min Jin LEE ; Sang Soo KIM ; In Joo KIM ; Sang Heon SONG ; Eun Heui KIM ; Ji Yeong SEO ; Jong Ho KIM ; Sungsu KIM ; Yun Kyung JEON ; Bo Hyun KIM ; Yong Ki KIM
Journal of Korean Medical Science 2017;32(5):782-788
Urinary angiotensinogen (AGT) is potentially a specific biomarker for the status of the intrarenal renin-angiotensin system (RAS) in patients with diabetes mellitus. We explored whether changes in urinary AGT excretion levels were associated with the deterioration of kidney function in type 2 diabetes patients with preserved kidney function. Urinary baseline AGT levels were measured in 118 type 2 diabetic patients who were not taking RAS blockers and who had estimated glomerular filtration rates (eGFRs) ≥ 60 mL/min/1.73 m². A total of 91 patients were followed-up for 52 months. Changes in urinary levels of AGT (ΔAGT) were calculated by subtracting urinary AGT/creatinine (Cr) at baseline from urinary AGT/Cr after 1 year. ΔAGT was significantly inversely correlated with annual eGFR change (β = −0.29, P = 0.006; β = −0.37, P = 0.001 after adjusting for clinical factors). RAS blockers were prescribed in 36.3% of patients (n = 33) during follow-up. The ΔAGT values were lower in the RAS blockers users than in the non-RAS blockers users, but the differences were not statistically significant (7.37 ± 75.88 vs. 22.55 ± 57.45 μg/g Cr, P = 0.081). The ΔAGT values remained significantly correlated with the annual rate of eGFR change (β = −0.41, P = 0.001) in the patients who did not use RAS blockers, but no such correlation was evident in the patients who did. ΔAGT is inversely correlated with annual changes in eGFR in type 2 diabetes patients with preserved kidney function, particularly in RAS blocker-naïve patients.
Angiotensinogen*
;
Diabetes Mellitus
;
Diabetes Mellitus, Type 2*
;
Diabetic Nephropathies
;
Follow-Up Studies
;
Glomerular Filtration Rate
;
Humans
;
Kidney*
;
Renin-Angiotensin System
4.Immunomodulatory effects of ethanol extract of germinated ice plant (Mesembryanthemum crystallinum).
Joo Hee CHOI ; Sung Gang JO ; Seoung Ki JUNG ; Woo Tae PARK ; Keun Young KIM ; Yong Wook PARK ; Jong Hwan PARK
Laboratory Animal Research 2017;33(1):32-39
The purpose of this study was to investigate the immunomodulatory activity of ice plant (Mesembryanthemum crystallinum) extract (IPE) in vitro and in vivo. Raji (a human B cell line) and Jurkat (a human T cell line) cells were treated with various doses of IPE and cell proliferation was measured by WST assay. Results showed that IPE promoted the proliferation of both Raji and Jurkat cells in a dose-dependent manner. IPE also enhanced IL-6 and TNF-α production in macrophages in the presence of lipopolysaccharide (LPS), although IPE alone did not induce cytokine production. Moreover, IPE treatment upregulated iNOS gene expression in macrophages in a time- and dose-dependent manner and led to the production of nitric oxide in macrophages in the presence of IFNγ. In vivo studies revealed that oral administration of IPE for 2 weeks increased the differentiation of CD4+, CD8+, and CD19+ cells in splenocytes. These findings suggested that IPE has immunomodulatory effects and could be developed as an immunomodulatory supplement.
Administration, Oral
;
Cell Proliferation
;
Cytokines
;
Ethanol*
;
Gene Expression
;
Humans
;
Ice*
;
In Vitro Techniques
;
Interleukin-6
;
Jurkat Cells
;
Lymphocytes
;
Macrophages
;
Mesembryanthemum*
;
Nitric Oxide
5.Impact of Pretreatment Hydronephrosis on the Success Rate of Shock Wave Lithotripsy in Patients with Ureteral Stone.
Ki Don CHANG ; Joo Yong LEE ; Sung Yoon PARK ; Dong Hyuk KANG ; Hyung Ho LEE ; Kang Su CHO
Yonsei Medical Journal 2017;58(5):1000-1005
PURPOSE: To evaluate predictors of the success rate for one session of shock wave lithotripsy (SWL), focusing on the relationships between pretreatment hydronephrosis grade and one-session SWL success rates. MATERIALS AND METHODS: The medical records of 1824 consecutive patients who underwent an initial session of SWL for treatment of urinary stones between 2005 and 2013 were reviewed. After exclusion, 700 patients with a single, 4–20 mm diameter radiopaque calculus were included in the study. RESULTS: The mean maximal stone length (MSL) and skin-to-stone distance were 9.2±3.9 and 110.8±18.9 mm, respectively. The average values for mean stone density (MSD) and stone heterogeneity index (SHI) were 707.0±272.1 and 244.9±110.1, respectively. One-session success rates were 68.4, 75.0, 75.1, 54.0, and 10.5% in patients with hydronephrosis grade 0, 1, 2, 3, and 4, respectively. Patients were classified into success or failure groups based on SWL outcome. Multivariate logistic regression analyses revealed that MSL [odds ratio (OR) 0.888, 95% confidence intervals (CI): 0.841–0.934, p<0.001], MSD (OR 0.996, 95% CI: 0.995–0.997, p<0.001), SHI (OR 1.007, 95% CI: 1.005–1.010, p<0.001), and pretreatment hydronephrosis grade (OR 0.601, 95% CI: 0.368–0.988, p=0.043) were significantly associated with one-session success. CONCLUSION: Pretreatment grades 3 or 4 hydronephrosis were associated with failure of SWL in patients with a single ureteral stone. In the presence of severe hydronephrosis, especially hydronephrosis grade 4; physicians should proceed cautiously in choosing and offering SWL as the primary treatment for ureteral stone.
Calculi
;
High-Energy Shock Waves
;
Humans
;
Hydronephrosis*
;
Lithotripsy*
;
Logistic Models
;
Medical Records
;
Population Characteristics
;
Shock*
;
Ureter*
;
Ureteral Calculi
;
Urinary Calculi
6.Routine Angiographic Follow-Up versus Clinical Follow-Up after Percutaneous Coronary Intervention in Acute Myocardial Infarction.
Yong Hoon KIM ; Ae Young HER ; Seung Woon RHA ; Byoung Geol CHOI ; Minsuk SHIM ; Se Yeon CHOI ; Jae Kyeong BYUN ; Hu LI ; Woohyeun KIM ; Jun Hyuk KANG ; Jah Yeon CHOI ; Eun Jin PARK ; Sung Hun PARK ; Sunki LEE ; Jin Oh NA ; Cheol Ung CHOI ; Hong Euy LIM ; Eung Ju KIM ; Chang Gyu PARK ; Hong Seog SEO ; Dong Joo OH
Yonsei Medical Journal 2017;58(4):720-730
PURPOSE: Differences in the utility of routine angiographic follow-up (RAF) and clinical follow-up (CF) after percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) are not well understood. The present study aimed to compare the 3-year clinical outcomes of RAF and CF in AMI patients who underwent PCI with drug-eluting stents (DES). MATERIALS AND METHODS: A total of 774 consecutive AMI patients who underwent PCI with DES were enrolled. RAF was performed at 6 to 9 months after index PCI (n=425). The remaining patients were medically managed and clinically followed (n=349); symptom-driven events were captured. To adjust for any potential confounders, a propensity score matched analysis was performed using a logistic regression model, and two propensity-matched groups (248 pairs, n=496, C-statistic=0.739) were generated. Cumulative clinical outcomes up to 3 years were compared between RAF and CF groups. RESULTS: During the 3-year follow-up period, the cumulative incidences of revascularization [target lesion revascularization: hazard ratio (HR), 2.40; 95% confidence interval (CI), 1.18–4.85; p=0.015, target vessel revascularization (TVR): HR, 3.33; 95% CI, 1.69–6.58; p=0.001, non-TVR: HR, 5.64; 95% CI, 1.90–16.6; p=0.002] and major adverse cardiac events (MACE; HR, 3.32; 95% CI, 1.92–5.73; p<0.001) were significantly higher in the RAF group than the CF group. However, the 3-year incidences of death and myocardial infarction were not different between the two groups. CONCLUSION: RAF following index PCI with DES in AMI patients was associated with increased incidences of revascularization and MACE. Therefore, CF seems warranted for asymptomatic patients after PCI for AMI.
Coronary Angiography
;
Drug-Eluting Stents
;
Follow-Up Studies*
;
Humans
;
Incidence
;
Logistic Models
;
Myocardial Infarction*
;
Percutaneous Coronary Intervention*
;
Propensity Score
7.Metronidazole-induced encephalopathy in a patient with Crohn's disease.
Jihye KIM ; Jaeyoung CHUN ; Jae Yong PARK ; Seung Wook HONG ; Joo Young LEE ; Jin Woo KANG ; Seongjun HWANG ; Sang Bae KO ; Jong Pil IM ; Joo Sung KIM
Intestinal Research 2017;15(1):124-129
Metronidazole is a widely used antibiotic for the treatment of anaerobic bacterial infections. Metronidazole-induced encephalopathy (MIEP) is a rare but potentially reversible disease. The mechanism of MIEP remains unclear, and differences in the neurotoxic effects of oral versus intravenous (IV) metronidazole administration have not yet been determined. We report the case of a Crohn's disease (CD) patient who experienced encephalopathy immediately after a single IV dose of metronidazole following long-term exposure to the oral form of the drug. The 64-year-old man with intractable CD experienced a sudden change in mental status, aphasia, and muscle weakness after IV administration of metronidazole. He had previously taken metronidazole orally for 13 years and received intermittent IV metronidazole treatments for CD exacerbation. Brain magnetic resonance imaging (MRI) showed high-intensity signals in the bilateral medial thalamus and the midbrain and pontine tegmentum on fluid-attenuated inversion recovery images. After discontinuation of metronidazole, the high-intensity brain MRI signals resolved and the patient's mental status dramatically improved; however, the patient exhibited mild cognitive dysfunction 2 months after the onset of encephalopathy.
Aphasia
;
Bacterial Infections
;
Brain
;
Brain Diseases*
;
Brain Diseases, Metabolic
;
Crohn Disease*
;
Drug-Related Side Effects and Adverse Reactions
;
Humans
;
Magnetic Resonance Imaging
;
Mesencephalon
;
Metronidazole
;
Middle Aged
;
Muscle Weakness
;
Pontine Tegmentum
;
Thalamus
8.Pre-treated Populus tomentiglandulosa extract inhibits neuronal loss and alleviates gliosis in the gerbil hippocampal CA1 area induced by transient global cerebral ischemia.
Joon Ha PARK ; Tae Kyeong LEE ; Ji Hyeon AHN ; Bich Na SHIN ; Jeong Hwi CHO ; In Hye KIM ; Jae Chul LEE ; Jong Dai KIM ; Young Joo LEE ; Il Jun KANG ; Seongkweon HONG ; Yang Hee KIM ; Yong Hwan JEON ; Yun Lyul LEE ; Moo Ho WON
Anatomy & Cell Biology 2017;50(4):284-292
The genus Populus (poplar) belonging to the Salicaceae family has been used in traditional medicine, and its several species show various pharmacological properties including antioxidant and anti-inflammatory effects. No study regarding protective effects of Populus species against cerebral ischemia has been reported. Therefore, in the present study, we examined neuroprotective effects of ethanol extract from Populus tomentiglandulosa (Korea poplar) in the hippocampal cornu ammonis (CA1) area of gerbils subjected to 5 minutes of transient global cerebral ischemia. Pretreatment with 200 mg/kg of P. tomentiglandulosa extract effectively protected CA1 pyramidal neurons from transient global cerebral ischemia. In addition, glial fibrillary acidic protein immunoreactive astrocytes and ionized calcium binding adapter molecule 1 immunoreactive microglia were significantly diminished in the ischemic CA1 area by pretreatment with 200 mg/kg of P. tomentiglandulosa extract. Briefly, our results indicate that pretreatment with P. tomentiglandulosa extract protects neurons from transient cerebral ischemic injury and diminish cerebral ischemia-induced reactive gliosis in ischemic CA1 area. Based on these results, we suggest that P. tomentiglandulosa can be used as a potential candidate for prevention of ischemic injury.
Astrocytes
;
Brain Ischemia*
;
Calcium
;
Ethanol
;
Gerbillinae*
;
Glial Fibrillary Acidic Protein
;
Gliosis*
;
Hippocampus
;
Humans
;
Medicine, Traditional
;
Microglia
;
Neurons*
;
Neuroprotective Agents
;
Populus*
;
Pyramidal Cells
;
Salicaceae
9.Clinical Significance of Preoperative Virtual Colonoscopy for Evaluation of the Proximal Colon in Patient With Obstructive Colorectal Cancer.
Jae Hyuk HEO ; Chun Geun RYU ; Eun Joo JUNG ; Jin Hee PAIK ; Dae Yong HWANG
Annals of Coloproctology 2017;33(4):130-133
PURPOSE: Virtual colonoscopy is the most recently developed tool for detecting colorectal cancers and polyps, but its effectiveness is limited. In our study, we compared the result of preoperative virtual colonoscopy to result of preoperative and postoperative colonoscopy. We evaluated also the accuracy of preoperative virtual colonoscopy in patients who had obstructive colorectal cancer that did not allow passage of a colonoscope. METHODS: A total of 164 patients who had undergone preoperative virtual colonoscopy and curative surgery after the diagnosis of a colorectal adenocarcinoma between November 2008 and August 2013 were pooled. We compared the result of conventional colonoscopy with that of virtual colonoscopy in the nonobstructive group and the results of preoperative virtual colonoscopy with that of postoperative colonoscopy performed at 6 months after surgery in the obstructive group. RESULTS: Of the 164 patients, 108 were male and 56 were female patients. The mean age was 62.7 years. The average sensitivity, specificity, and accuracy of virtual colonoscopy for all patients were 31.0%, 67.2%, and 43.8%, respectively. In the nonobstructive group, the average sensitivity, specificity, and accuracy were 36.6%, 66.2%, and 48.0%, respectively, whereas in the obstructive group, they were 2%, 72.4%, and 25.4%. Synchronous cancer was detected via virtual colonoscopy in 4 of the 164 patients. CONCLUSION: Virtual colonoscopy may not be an effective method for the detection of proximal colon polyps, but it can be helpful in determining the therapeutic plan when its results are correlated with the results of other studies.
Adenocarcinoma
;
Colon*
;
Colonic Polyps
;
Colonography, Computed Tomographic*
;
Colonoscopes
;
Colonoscopy
;
Colorectal Neoplasms*
;
Diagnosis
;
Female
;
Humans
;
Male
;
Methods
;
Polyps
;
Sensitivity and Specificity
10.Bowel Perforation Due to Immobilization after Resurfacing Thumb with Anterolateral Thigh Free Flap in an Elderly Diabetic Woman.
Seong Hoon PARK ; Joo Hyun KIM ; In Suck SUH ; Kwang Yong KIM ; Hii Sun JEONG
Archives of Reconstructive Microsurgery 2017;26(1):18-22
Inevitable immobilization after surgery on lower extremities can induce chronic constipation. Elderly diabetic women usually express ambiguous gastrointestinal symptoms and signs. We present here a case of panperitonitis developed from severe fecal impaction in an elderly diabetic woman after hand reconstruction using material harvested from the lower extremities. A 68-year-old diabetic female underwent anterolateral thigh free flap and wound revision twice on the left thumb. Three weeks after surgery, she complained about mild abdominal pain though she had daily defecation. Despite encouraging ambulation, her compliance was low. Resection of the sigmoid colon and colostomy were performed after diagnosis with bowel perforation. However, the patient went into septic shock and died with multiorgan failure after the guardians issued a DNR (do not resuscitate) order. For preventing bowel perforation, increased uptake of dietary fiber and early ambulation postoperatively should be encouraged, after even hand surgeries.
Abdominal Pain
;
Aged*
;
Colon, Sigmoid
;
Colostomy
;
Compliance
;
Constipation
;
Defecation
;
Diabetes Complications
;
Diagnosis
;
Dietary Fiber
;
Disabled Persons
;
Early Ambulation
;
Fecal Impaction
;
Female
;
Free Tissue Flaps*
;
Hand
;
Humans
;
Immobilization*
;
Lower Extremity
;
Shock, Septic
;
Thigh*
;
Thumb*
;
Walking
;
Wounds and Injuries

Result Analysis
Print
Save
E-mail